Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

The secrets behind GSK's strategic sauce

This article was originally published in Scrip

Executive Summary

Brian McVeigh says that GlaxoSmithKline PLC is in a unique position amongst its pharma peers; instead of scrambling to fill its late-stage pipeline, it is working to build the pipeline after that, and the pipeline after that.